
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
David Ramonet, Agata Podhajska, Klodjan Stafa, et al.
Human Molecular Genetics (2011) Vol. 21, Iss. 8, pp. 1725-1743
Open Access | Times Cited: 156
David Ramonet, Agata Podhajska, Klodjan Stafa, et al.
Human Molecular Genetics (2011) Vol. 21, Iss. 8, pp. 1725-1743
Open Access | Times Cited: 156
Showing 1-25 of 156 citing articles:
Manganese Is Essential for Neuronal Health
Kyle J. Horning, Samuel Caito, K. Grace Tipps, et al.
Annual Review of Nutrition (2015) Vol. 35, Iss. 1, pp. 71-108
Open Access | Times Cited: 509
Kyle J. Horning, Samuel Caito, K. Grace Tipps, et al.
Annual Review of Nutrition (2015) Vol. 35, Iss. 1, pp. 71-108
Open Access | Times Cited: 509
Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
Jin‐Sung Park, Ryan L. Davis, Carolyn M. Sue
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 5
Open Access | Times Cited: 494
Jin‐Sung Park, Ryan L. Davis, Carolyn M. Sue
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 5
Open Access | Times Cited: 494
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
Preston Ge, Valina L. Dawson, Ted M. Dawson
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 373
Parkinson’s Disease
Timothy R. Mhyre, James T. Boyd, Robert W. Hamill, et al.
Sub-cellular biochemistry/Subcellular biochemistry (2012), pp. 389-455
Open Access | Times Cited: 344
Timothy R. Mhyre, James T. Boyd, Robert W. Hamill, et al.
Sub-cellular biochemistry/Subcellular biochemistry (2012), pp. 389-455
Open Access | Times Cited: 344
Lysosomal impairment in Parkinson's disease
Benjamin Dehay, Marta Martínez‐Vicente, Guy A. Caldwell, et al.
Movement Disorders (2013) Vol. 28, Iss. 6, pp. 725-732
Open Access | Times Cited: 302
Benjamin Dehay, Marta Martínez‐Vicente, Guy A. Caldwell, et al.
Movement Disorders (2013) Vol. 28, Iss. 6, pp. 725-732
Open Access | Times Cited: 302
Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
Tim E. Moors, Jeroen J.M. Hoozemans, Angela Ingrassia, et al.
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 249
Tim E. Moors, Jeroen J.M. Hoozemans, Angela Ingrassia, et al.
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 249
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Ziv Gan‐Or, Patrick A. Dion, Guy A. Rouleau
Autophagy (2015) Vol. 11, Iss. 9, pp. 1443-1457
Open Access | Times Cited: 245
Ziv Gan‐Or, Patrick A. Dion, Guy A. Rouleau
Autophagy (2015) Vol. 11, Iss. 9, pp. 1443-1457
Open Access | Times Cited: 245
The Neuronal Ceroid-Lipofuscinoses (Batten Disease)
Sara Mole, Matti Haltia
Elsevier eBooks (2014), pp. 793-808
Closed Access | Times Cited: 225
Sara Mole, Matti Haltia
Elsevier eBooks (2014), pp. 793-808
Closed Access | Times Cited: 225
Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation
Julie Jerber, Daniel D. Seaton, Anna Cuomo, et al.
Nature Genetics (2021) Vol. 53, Iss. 3, pp. 304-312
Open Access | Times Cited: 220
Julie Jerber, Daniel D. Seaton, Anna Cuomo, et al.
Nature Genetics (2021) Vol. 53, Iss. 3, pp. 304-312
Open Access | Times Cited: 220
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes
Stephanie M.Y. Kong, Brian K.K. Chan, Jin‐Sung Park, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 11, pp. 2816-2833
Open Access | Times Cited: 212
Stephanie M.Y. Kong, Brian K.K. Chan, Jin‐Sung Park, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 11, pp. 2816-2833
Open Access | Times Cited: 212
Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression
Anastasia G. Henry, Soheil Aghamohammadzadeh, Harry Samaroo, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 21, pp. 6013-6028
Open Access | Times Cited: 207
Anastasia G. Henry, Soheil Aghamohammadzadeh, Harry Samaroo, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 21, pp. 6013-6028
Open Access | Times Cited: 207
Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment
Jia Liu, Weijin Liu, Ruolin Li, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 712-712
Open Access | Times Cited: 188
Jia Liu, Weijin Liu, Ruolin Li, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 712-712
Open Access | Times Cited: 188
Mitophagy and Oxidative Stress: The Role of Aging
Anna De Gaetano, Lara Gibellini, Giada Zanini, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 794-794
Open Access | Times Cited: 114
Anna De Gaetano, Lara Gibellini, Giada Zanini, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 794-794
Open Access | Times Cited: 114
The neuronal ceroid-lipofuscinoses (Batten disease)
Sara Mole, Angela Schulz
Elsevier eBooks (2024), pp. 59-79
Closed Access | Times Cited: 19
Sara Mole, Angela Schulz
Elsevier eBooks (2024), pp. 59-79
Closed Access | Times Cited: 19
Metal Ion Signaling in Biomedicine
Raphaël Rodriguez, Sebastian Müller, Ludovic Colombeau, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
Raphaël Rodriguez, Sebastian Müller, Ludovic Colombeau, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
The role of Ca2+ signaling in Parkinson's disease
Sofia Zaichick, Kaitlyn M. McGrath, Gabriela Caraveo
Disease Models & Mechanisms (2017) Vol. 10, Iss. 5, pp. 519-535
Open Access | Times Cited: 165
Sofia Zaichick, Kaitlyn M. McGrath, Gabriela Caraveo
Disease Models & Mechanisms (2017) Vol. 10, Iss. 5, pp. 519-535
Open Access | Times Cited: 165
ATP13A2/PARK9 Regulates Secretion of Exosomes and α-Synuclein
Taiji Tsunemi, Kana Hamada, Dimitri Krainc
Journal of Neuroscience (2014) Vol. 34, Iss. 46, pp. 15281-15287
Open Access | Times Cited: 157
Taiji Tsunemi, Kana Hamada, Dimitri Krainc
Journal of Neuroscience (2014) Vol. 34, Iss. 46, pp. 15281-15287
Open Access | Times Cited: 157
The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms
Jin‐Sung Park, Nicholas Blair, Carolyn M. Sue
Movement Disorders (2015) Vol. 30, Iss. 6, pp. 770-779
Closed Access | Times Cited: 154
Jin‐Sung Park, Nicholas Blair, Carolyn M. Sue
Movement Disorders (2015) Vol. 30, Iss. 6, pp. 770-779
Closed Access | Times Cited: 154
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Sonia Levi, Dario Finazzi
Frontiers in Pharmacology (2014) Vol. 5
Open Access | Times Cited: 154
Sonia Levi, Dario Finazzi
Frontiers in Pharmacology (2014) Vol. 5
Open Access | Times Cited: 154
Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)
Alejandro Estrada‐Cuzcano, Shaun Martin, Teodora Chamova, et al.
Brain (2016) Vol. 140, Iss. 2, pp. 287-305
Open Access | Times Cited: 148
Alejandro Estrada‐Cuzcano, Shaun Martin, Teodora Chamova, et al.
Brain (2016) Vol. 140, Iss. 2, pp. 287-305
Open Access | Times Cited: 148
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
Elpida Tsika, Liliane Glauser, Ralf Moser, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 17, pp. 4621-4638
Open Access | Times Cited: 147
Elpida Tsika, Liliane Glauser, Ralf Moser, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 17, pp. 4621-4638
Open Access | Times Cited: 147
Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation
Taiji Tsunemi, Dimitri Krainc
Human Molecular Genetics (2013) Vol. 23, Iss. 11, pp. 2791-2801
Open Access | Times Cited: 144
Taiji Tsunemi, Dimitri Krainc
Human Molecular Genetics (2013) Vol. 23, Iss. 11, pp. 2791-2801
Open Access | Times Cited: 144
Endocytic membrane trafficking and neurodegenerative disease
Andrea M. A. Schreij, Edward A. Fon, Peter S. McPherson
Cellular and Molecular Life Sciences (2015) Vol. 73, Iss. 8, pp. 1529-1545
Open Access | Times Cited: 143
Andrea M. A. Schreij, Edward A. Fon, Peter S. McPherson
Cellular and Molecular Life Sciences (2015) Vol. 73, Iss. 8, pp. 1529-1545
Open Access | Times Cited: 143
A Mitocentric View of Parkinson's Disease
Nele A. Haelterman, Wan Hee Yoon, Héctor Sandoval, et al.
Annual Review of Neuroscience (2014) Vol. 37, Iss. 1, pp. 137-159
Open Access | Times Cited: 140
Nele A. Haelterman, Wan Hee Yoon, Héctor Sandoval, et al.
Annual Review of Neuroscience (2014) Vol. 37, Iss. 1, pp. 137-159
Open Access | Times Cited: 140
Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction
Jin-Sung Park, Brianada Koentjoro, David Veivers, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 11, pp. 2802-2815
Open Access | Times Cited: 137
Jin-Sung Park, Brianada Koentjoro, David Veivers, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 11, pp. 2802-2815
Open Access | Times Cited: 137